Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.

Purpose: Myeloproliferative neoplasm (MPN) symptoms are troublesome to patients, and alleviation of this burden represents a paramount treatment objective in the development of MPN-directed therapies. We aimed to assess the utility of an abbreviated symptom score for the most pertinent and represent...

Full description

Saved in:
Bibliographic Details
Main Authors: Scherber, Robyn M. (Author) , Bonatz, Karin (Author) , Reiter, Andreas (Author)
Format: Article (Journal)
Language:English
Published: November 20, 2012
In: Journal of clinical oncology
Year: 2012, Volume: 30, Issue: 33, Pages: 4098-4103
ISSN:1527-7755
DOI:10.1200/JCO.2012.42.3863
Online Access:Verlag, Volltext: http://ascopubs.org/doi/10.1200/JCO.2012.42.3863
Verlag, Volltext: http://dx.doi.org/10.1200/JCO.2012.42.3863
Get full text
Author Notes:Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer, Jean-Jacques Kiladjian, Stefanie Slot, Sonja Zweegman, Peter A.W. te Boekhorst, Suzan Commandeur, Harry C. Schouten, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernández-Maraver, Heike L. Pahl, Martin Griesshammer, Frank Stegelmann, Konstanze Doehner, Thomas Lehmann, Karin Bonatz, Andreas Reiter, Francoise Boyer, Gabriel Etienne, Jean-Christophe Ianotto, Dana Ranta, Lydia Roy, Jean-Yves Cahn, Claire N. Harrison, Deepti Radia, Pablo Muxi, Norman Maldonado, Carlos Besses, Francisco Cervantes, Peter L. Johansson, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi, Francesco Passamonti, Bjorn Andreasson, Maria L. Ferarri, Alessandro Rambaldi, Jan Samuelsson, Gunnar Birgegard, Ayalew Tefferi, Ruben A. Mesa

MARC

LEADER 00000caa a2200000 c 4500
001 1584482958
003 DE-627
005 20230427161329.0
007 cr uuu---uuuuu
008 181126s2016 xx |||||o 00| ||eng c
024 7 |a 10.1200/JCO.2012.42.3863  |2 doi 
035 |a (DE-627)1584482958 
035 |a (DE-576)514482958 
035 |a (DE-599)BSZ514482958 
035 |a (OCoLC)1341024443 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Scherber, Robyn M.  |e VerfasserIn  |0 (DE-588)1172254125  |0 (DE-627)1041059671  |0 (DE-576)514482664  |4 aut 
245 1 0 |a Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score  |b prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.  |c Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer, Jean-Jacques Kiladjian, Stefanie Slot, Sonja Zweegman, Peter A.W. te Boekhorst, Suzan Commandeur, Harry C. Schouten, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernández-Maraver, Heike L. Pahl, Martin Griesshammer, Frank Stegelmann, Konstanze Doehner, Thomas Lehmann, Karin Bonatz, Andreas Reiter, Francoise Boyer, Gabriel Etienne, Jean-Christophe Ianotto, Dana Ranta, Lydia Roy, Jean-Yves Cahn, Claire N. Harrison, Deepti Radia, Pablo Muxi, Norman Maldonado, Carlos Besses, Francisco Cervantes, Peter L. Johansson, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi, Francesco Passamonti, Bjorn Andreasson, Maria L. Ferarri, Alessandro Rambaldi, Jan Samuelsson, Gunnar Birgegard, Ayalew Tefferi, Ruben A. Mesa 
264 1 |c November 20, 2012 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online ahead of print at www.jco.org on October 15, 2012 
500 |a Gesehen am 26.11.2018 
520 |a Purpose: Myeloproliferative neoplasm (MPN) symptoms are troublesome to patients, and alleviation of this burden represents a paramount treatment objective in the development of MPN-directed therapies. We aimed to assess the utility of an abbreviated symptom score for the most pertinent and representative MPN symptoms for subsequent serial use in assessing response to therapy. Patients and Methods: The Myeloproliferative Neoplasm Symptom Assessment Form total symptom score (MPN-SAF TSS) was calculated as the mean score for 10 items from two previously validated scoring systems. Questions focus on fatigue, concentration, early satiety, inactivity, night sweats, itching, bone pain, abdominal discomfort, weight loss, and fevers. Results: MPN-SAF TSS was calculable for 1,408 of 1,433 patients with MPNs who had a mean score of 21.2 (standard deviation [SD], 16.3). MPN-SAF TSS results significantly differed among MPN disease subtypes (P < .001), with a mean of 18.7 (SD, 15.3), 21.8 (SD, 16.3), and 25.3 (SD, 17.2) for patients with essential thrombocythemia, polycythemia vera, and myelofibrosis, respectively. The MPN-SAF TSS strongly correlated with overall quality of life (QOL; r = 0.59; P < .001) and European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) functional scales (all P < .001 and absolute r ≥ 0.50 except social functioning r = 0.48). No significant trends were present when comparing therapy subgroups. The MPN-SAF TSS had excellent internal consistency (Cronbach's α = .83). Factor analysis identified a single underlying construct, indicating that the MPN-SAF TSS is an appropriate, unified scoring method. Conclusion: The MPN-SAF TSS is a concise, valid, and accurate assessment of MPN symptom burden with demonstrated clinical utility in the largest prospective MPN symptom study to date. This new prospective scoring method may be used to assess MPN symptom burden in both clinical practice and trial settings. 
700 1 |a Bonatz, Karin  |e VerfasserIn  |0 (DE-588)116025995X  |0 (DE-627)1023409569  |0 (DE-576)167430327  |4 aut 
700 1 |a Reiter, Andreas  |d 1964-  |e VerfasserIn  |0 (DE-588)172629551  |0 (DE-627)697563766  |0 (DE-576)133488594  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical oncology  |d Alexandria, Va. : American Society of Clinical Oncology, 1983  |g 30(2012), 33, Seite 4098-4103  |h Online-Ressource  |w (DE-627)313116962  |w (DE-600)2005181-5  |w (DE-576)090887018  |x 1527-7755  |7 nnas  |a Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. 
773 1 8 |g volume:30  |g year:2012  |g number:33  |g pages:4098-4103  |g extent:6  |a Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. 
856 4 0 |u http://ascopubs.org/doi/10.1200/JCO.2012.42.3863  |x Verlag  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1200/JCO.2012.42.3863  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20181126 
993 |a Article 
994 |a 2012 
998 |g 172629551  |a Reiter, Andreas  |m 172629551:Reiter, Andreas  |d 60000  |d 61200  |e 60000PR172629551  |e 61200PR172629551  |k 0/60000/  |k 1/60000/61200/  |p 19 
998 |g 116025995X  |a Bonatz, Karin  |m 116025995X:Bonatz, Karin  |d 60000  |d 61200  |e 60000PB116025995X  |e 61200PB116025995X  |k 0/60000/  |k 1/60000/61200/  |p 18 
999 |a KXP-PPN1584482958  |e 3034141947 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer, Jean-Jacques Kiladjian, Stefanie Slot, Sonja Zweegman, Peter A.W. te Boekhorst, Suzan Commandeur, Harry C. Schouten, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernández-Maraver, Heike L. Pahl, Martin Griesshammer, Frank Stegelmann, Konstanze Doehner, Thomas Lehmann, Karin Bonatz, Andreas Reiter, Francoise Boyer, Gabriel Etienne, Jean-Christophe Ianotto, Dana Ranta, Lydia Roy, Jean-Yves Cahn, Claire N. Harrison, Deepti Radia, Pablo Muxi, Norman Maldonado, Carlos Besses, Francisco Cervantes, Peter L. Johansson, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi, Francesco Passamonti, Bjorn Andreasson, Maria L. Ferarri, Alessandro Rambaldi, Jan Samuelsson, Gunnar Birgegard, Ayalew Tefferi, Ruben A. Mesa"]},"note":["Published online ahead of print at www.jco.org on October 15, 2012","Gesehen am 26.11.2018"],"title":[{"subtitle":"prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.","title":"Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score","title_sort":"Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score"}],"physDesc":[{"extent":"6 S."}],"language":["eng"],"id":{"eki":["1584482958"],"doi":["10.1200/JCO.2012.42.3863"]},"recId":"1584482958","origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"November 20, 2012"}],"relHost":[{"disp":"Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.Journal of clinical oncology","part":{"extent":"6","issue":"33","year":"2012","text":"30(2012), 33, Seite 4098-4103","pages":"4098-4103","volume":"30"},"pubHistory":["1.1983 -"],"corporate":[{"display":"American Society of Clinical Oncology","role":"isb"}],"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"313116962","note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal","title":"Journal of clinical oncology"}],"origin":[{"publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","dateIssuedDisp":"1983-","dateIssuedKey":"1983","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]"}],"id":{"zdb":["2005181-5"],"eki":["313116962"],"issn":["1527-7755"]}}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"family":"Scherber","display":"Scherber, Robyn M.","role":"aut","given":"Robyn M."},{"given":"Karin","display":"Bonatz, Karin","family":"Bonatz","role":"aut"},{"given":"Andreas","display":"Reiter, Andreas","family":"Reiter","role":"aut"}]} 
SRT |a SCHERBERROMYELOPROLI2020